Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosis. Carvalho T. Nat Med 2023 Jul 5. doi: 10.1038/d41591-023-00060.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Carvalho T. Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosis. Nat Med 2023 Jul 5. doi: 10.1038/d41591-023-00060.
PMID: 37407835